Musculoskeletal symptoms in SARS-CoV-2 (COVID-19) patients
Open accessThe DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Abstract
The novel SARS-CoV-2 (COVID-19) became a pandemic on 11 March 2020.The epidemiological picture is constantly evolving, and on 13 May, 4,170,424 cases and 287,399 confirmed deaths have been reported (WHO Report).People with COVID-19 infection may show several symptoms, including fever, cough, nausea, vomiting, dyspnea, myalgia, fatigue, arthralgia, headache, diarrhea, and rarely arthritis [1].COVID-19 clinical features range from asymptomatic patients to acute respiratory distress syndrome (ARDS) and multiple organ dysfunction [2,3].Influenza symptoms are associated with a cascade of inflammatory mediators.Interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) levels in plasma and upper respiratory secretions directly correlate with the magnitude of viral replication, fever, and respiratory and systemic symptoms, including musculoskeletal clinical manifestations [4,5] Musculoskeletal symptoms such as fatigue, myalgia and arthralgia are common COVID-19 symptoms, but their prevalence has not yet been systematically investigated [6,7].We collected the published clinical data of the past 5 months to ascertain the prevalence of musculoskeletal symptoms and epidemiological characteristics published worldwide in COVID-19 patients.Data were tabulated using Microsoft Excel TM 2020 V.16.34.The value was showed as mean ± SD.Student t test was used to reveal musculoskeletal symptoms between the total sample.To assess the incidence for each clinical variable, frequency analysis was performed.Regression analysis (R 2 ) was used to examine correlations between the total sample and musculoskeletal symptoms extracted.The level of significant was set at p < 0.05.The relevant reference and the data collected from the included articles are indicated in Tables 1 and2.Data on 12,046 patients (54% male and 46% females) were available.The number of patients in the selected studies ranged from 5 to 1590 patients (223 ± 312 patients).The sex ratio (male to female) was 1:15, and the overall average of patients was 52.13 years.The majority of the studies arose from China, mainly from Wuhan; one was from Singapore [57], two from Europe [46,59], one from the USA [36], and one from Bolivia [58].Musculoskeletal symptoms were present from the earliest stage of the viral illness and were reported in patients necessitating intensive care in the end stage of the condition.The total prevalence of fatigue symptom was 25.6% (R 2 =0.56; p value = 0.004), while the prevalence of arthralgia and/or myalgia was 15.5% (R 2 = 0.66; p value = 0.001; Fig. 1).Eight studies reported a prevalence higher than 50% of patients with fatigue [8,9,24,25,28,37,46,47], while three studies reported higher values for arthralgia/myalgia symptoms [50,53,59].The prevalence of musculoskeletal symptoms in studies from Europe reached high values [46,59]; Lechien et al., for example, reported on 417 COVID-19 patients from 12 European hospitals and found myalgia in 246 (59%) and arthralgia in 129 (31%) of these patients [59].Clinical presentation of COVID-19 ranges from absence of symptoms to severe pneumonia.Fever, dry cough and fatigue are common symptoms, as indeed are myalgia and arthralgia [6,53].Most of the articles are retrospective single center studies: data were collected in a non-homogeneous way, especially regarding comorbidities, lifestyle habits, and severity of the illness.Based on our work, we cannot state, for example, whether children and younger patients less commonly present musculoskeletal symptoms at onset [63].Most studies originate from China, which is not surprising, and it is not clear whether the prevalence of musculoskeletal
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415 · cited 1×
“symptoms at onset is influenced by socio-geographical factors [64].”
BackgroundYang, X., Yu, Y., Xu, J., Shu, H., Xia, J., Liu, H., Wu, Y., Zhang, L., Yu, Z., Fang, M., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30079-5 · Cited by 10,066 · cited 1×
“The most common symptoms in patients with mild to moderate clinical presentation of the condition are fever, fatigue, and dry cough, followed by other symptoms including headache, nasal congestion, sore throat, myalgia, and arthralgia [65, 66].”
BackgroundWang, C., Pan, R., Wan, X., Tan, Y., Xu, L., Ho, C. S., & Ho, R. C. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17051729 · Cited by 9,923 · cited 1×
“Based on our work, we cannot state, for example, whether children and younger patients less commonly present musculoskeletal symptoms at onset [63].”
BackgroundCOVID-19: consider cytokine storm syndromes and immunosuppression
Mehta, P., McAuley, D. F., Brown, M., Sanchez, E., Tattersall, R. S., & Manson, J. J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30628-0 · Cited by 9,664
Wu, C., Chen, X., Cai, Y., Xia, J., Zhou, X., Xu, S., Huang, H., Zhang, L., Zhou, X., Du, C., et al. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.0994 · Cited by 8,249
Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China
Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yang, Y.-B., Yan, Y.-Q., Akdis, C. A., & Gao, Y.-D. (2020) · Allergy · doi:10.1111/all.14238 · Cited by 4,004
Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study
Chen, T., Wu, D., Chen, H., Yan, W., Yang, D., Chen, G., Ma, K., Xu, D., Yu, H., Wang, H., et al. (2020) · BMJ · doi:10.1136/bmj.m1091 · Cited by 3,903
Cited by
Physical and mental health complications post-COVID-19: Scoping review
Shanbehzadeh, S., Tavahomi, M., Zanjari, N., Ebrahimi-Takamjani, I., & Amiri-arimi, S. (2021) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2021.110525 · Cited by 334
“Common characteristics of the acute stage of the disease are fever, musculoskeletal symptoms (fatigue, myalgia, and joint pain), dry cough, dyspnea, gastrointestinal symptoms, and anosmia with or without ageusia [3].”
Metadata
- Authors
- Cipollaro, L., Giordano, L., Padulo, J., Oliva, F., & Maffulli, N.
- Venue
- Journal of Orthopaedic Surgery and Research
- Published
- 2020-05-18
- Volume
- 15
- Issue
- 1
- Pages
- 178-178
- ISSN
- 1749-799X (ISSN-L)
- OpenAlex
- W3024722220
- Cited by
- 177
- References
- 68
- FWCI
- 4.86
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Musculoskeletal symptoms in SARS-CoV-2 (COVID-19) patients. https://app.cochat.ai/papers/10.1186/s13018-020-01702-w
- The paper
- Cipollaro, L., Giordano, L., Padulo, J., Oliva, F., & Maffulli, N. (2020). Musculoskeletal symptoms in SARS-CoV-2 (COVID-19) patients. Journal of Orthopaedic Surgery and Research. https://doi.org/10.1186/s13018-020-01702-w
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.